No Data
No Data
60 Degrees Pharmaceuticals and Can-Fite BioPharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
60 Degrees Pharmaceuticals Inc. (SXTP) Reports Q3 Loss, Misses Revenue Estimates
60 Degrees Pharmaceuticals 3Q Loss/Shr 93c >SXTP
Express News | 60 Degrees Q3 2024 GAAP EPS $(0.93) Misses $(0.70) Estimate, Sales $135.00K Miss $242.00K Estimate
Express News | 60 Degrees Pharmaceuticals Announces Third Quarter 2024 Results
10-Q: Q3 2024 Earnings Report
No Data